Back

Reporting quality of randomised controlled trials investigating efficacy of pharmacological therapies for heart failure with preserved ejection fraction

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - HFpEF - Heart failure with preserved ejection fraction HFpEF - Heart failure with preserved ejection fraction HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Sean Zheng

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
The role of diastolic heart failure in the development of atrial fibrillation paroxysms in patients with hypertension
Doctor D. Pilant (Minsk, BY)
Presentation thumbnail
Features of very elderly heart failure patients between heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.
Mr K. Satogami (Shingu, JP)
Abstract Slides
Presentation thumbnail
Heart failure with preserved ejection fraction: is the role of arterial stiffness established?
Doctor E. Gorga (Brescia, IT)
Abstract Slides
Presentation thumbnail
Timing of left ventricular deformation and dyssynchrony in HFpEF and treated arterial hypertension
Professor M. Cikes (Zagreb, HR)
Abstract
Presentation thumbnail
Diagnosis, clinical course and one-year outcome in patients hospitalized for heart failure with preserved ejection fraction - results from the polish cohort of the ESC-HF long-term registry
Professor A. Kaplon Cieslicka (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - HFpEF - Heart failure with preserved ejection fraction

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources